Physician profile
Ryan K Riggs
NPI 1669415881
$1,546.79
in general payments reported to CMS, 2019-2025
11 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $592 · 2020: $217 · 2021: $181 · 2022: $152 · 2023: $192 · 2024: $46.57 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $404.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $289.80 | 2019-2022 | |
| Bioventus LLC | $255.24 | 2019-2023 | Durolane |
| Pacira Therapeutics, INC. | $233.98 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $212.81 | 2024-2025 | Zilretta, Iovera |
| Depuy Synthes Sales INC. | $164.54 | 2019-2023 | Orthovisc, Monovisc, Peak |
| Stryker Corporation | $125.21 | 2019 | |
| Zimmer Biomet Holdings, INC. | $86.07 | 2023 | |
| Avanos Medical | $84.99 | 2019-2023 | Genvisc 850 Sodium Hyaluronate |
| Orthogenrx INC. | $50.48 | 2019 | |
| Sanofi-Aventis U.S. LLC | $29.01 | 2019-2023 | |
| Emd Serono, INC. | $14.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Riggs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.